Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Conclusions Adjuvant DXP is feasible and effective for patients with stage IIIB–IV GC. A phase 3 study comparing triplet and doublet regimens for these patients is ongoing.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research